Dirk P.
- Country
- Germany
- Department
- NA
Research Overview
- Pharmacokinetic Bridging Study of Tozorakimab Using an Accessorised Prefilled Syringe and Autoinjector in Patients with Respiratory Inflammation
- A Phase I, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of EGL-003 in Healthy Volunteers and Adults with Atopic Dermatitis
- A Phase I Study to Evaluate the Pharmacokinetics and Safety of a Single Dose of Duvakitug in Healthy Adult Participants
Data & Insights
Has run more than one trial at 1 of 12 partner sites.
Specializations
Cardiovascular Research
The investigator specializes in studying cardiovascular therapeutics with particular focus on ticagrelor and its interactions with other medications such as rosuvastatin.
- Drug Interactions
- Lipid Management
- Cardiorenal Disease
Their research extends to cardiorenal conditions, investigating novel therapeutic approaches for patients with complex cardiovascular needs.
Metabolic Disorders
The investigator conducts research in metabolic health, with emphasis on obesity management and type 2 diabetes in postmenopausal women.
- Obesity Therapeutics
- Postmenopausal Health
- Gastric Motility
Their work includes studies on novel compounds affecting stomach emptying and metabolic parameters.
Respiratory and Inflammatory Conditions
The investigator explores innovative biological therapies in respiratory medicine and inflammatory disorders, including research on tozorakimab.
- Biological Therapeutics
- Drug Delivery Systems
- Inflammatory Pathways
Their research includes evaluation of different drug administration methods and delivery systems.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.